Oxbridge Re Holdings Limited (NASDAQ:OXBR – Get Free Report) was the recipient of a significant growth in short interest during the month of July. As of July 31st, there was short interest totaling 25,578 shares, a growth of 282.5% from the July 15th total of 6,687 shares. Approximately 0.4% of the company’s stock are short sold. Based on an average daily volume of 26,904 shares, the short-interest ratio is currently 1.0 days.
Analyst Ratings Changes
Several equities research analysts have issued reports on the company. Zacks Research upgraded Oxbridge Re to a “hold” rating in a report on Wednesday, June 17th. Maxim Group reduced their target price on Oxbridge Re from $5.00 to $3.00 and set a “buy” rating for the company in a research note on Tuesday, June 16th. Finally, Weiss Ratings raised shares of Oxbridge Re from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, July 28th. One analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $3.00.
View Our Latest Stock Report on OXBR
Oxbridge Re Stock Performance
Institutional Trading of Oxbridge Re
Institutional investors and hedge funds have recently bought and sold shares of the company. Virtu Financial LLC bought a new position in Oxbridge Re during the 3rd quarter worth approximately $32,000. International Assets Investment Management LLC acquired a new position in shares of Oxbridge Re in the 4th quarter worth approximately $39,000. Finally, J.W. Cole Advisors Inc. increased its holdings in shares of Oxbridge Re by 106.1% in the 4th quarter. J.W. Cole Advisors Inc. now owns 68,000 shares of the insurance provider’s stock valued at $90,000 after acquiring an additional 35,000 shares during the last quarter. Institutional investors and hedge funds own 5.64% of the company’s stock.
About Oxbridge Re
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
See Also
- Five stocks we like better than Oxbridge Re
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
